INMB today
$1.05-$0.05 (-4.55%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $1.69
Key levels
Resistance$1.25
Resistance$1.09
Latest news & SEC filings
EarningsINmune Bio Reports Third Quarter 2026 Financial Results
EarningsINmune Bio holds Q3 2026 earnings call
EarningsINmune Bio posts wider third-quarter loss than expected
All INMB news →About Inmune Bio
This biotechnology firm focuses on medicines that reprogram the body's innate immune response. Its main candidate, CORDStrom, uses pooled umbilical cord-derived stromal cells to treat a rare inherited skin-blistering disorder. Another program, XPro1595, targets neuroinflammation in Alzheimer's disease, while INKmune aims to prime natural killer cells against cancer. Activities span the United States, Britain, and Europe.
Based on the company's 10-K filed Mar 30, 2026.
Nasdaq · Healthcare
Inmune Bio, Inc. (INMB)
What Is the Price Target for INMB?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is INMB a Buy or Sell Right Now?
Thesis
- •Revenue growing 257.1% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for INMB.
Start Free Trial →Is INMB Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B
Fair Value
$1.99
25
Moat Score
NONE
3/9
Piotroski Score
-10.9
Altman Z-Score
What Is Smart Money Doing with INMB?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →INMB Growth Story
Revenue YoY
257.1%
3yr Revenue CAGR
-48.9%
EPS Growth YoY
11.85%
FCF Growth YoY
N/A%
Revenue Trend
ACCELERATING
Dark Pool Trades for INMB
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for INMB, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:59:51 | $1.04 | 1,600 | $$2K | SELL |
| 20:39:54 | $1.07 | 3,201 | $$3K | BUY |
| 20:36:16 | $1.05 | 1,084 | $$1K | BUY |
| 20:36:12 | $1.05 | 1,711 | $$2K | BUY |
| 20:10:11 | $1.04 | 1,100 | $$1K | SELL |
5 dark pool trades shown · $$9K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Inmune Bio, Inc. (INMB) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →INMB — frequently asked questions
What is INMB stock price today?
Inmune Bio, Inc. (INMB) is at $1.05, down 4.55% (-$0.05) at the Nov 12, 2026 close.
Why is INMB stock moving today?
Latest INMB news — Nov 6, 2026: INmune Bio Reports Third Quarter 2026 Financial Results · Nov 5, 2026: INmune Bio holds Q3 2026 earnings call
What do analysts rate INMB?
Analyst ratings for INMB: 4 Buy, 0 Hold, 0 Sell — consensus Strong Buy.
Did INMB beat earnings?
INMB last reported on Aug 6, 2026: EPS -$0.05 vs -$0.21 expected — a beat of 75.8%.
Does INMB pay a dividend?
INMB does not currently pay a dividend.
What are INMB support and resistance levels?
Resistance: $1.09, $1.25, $1.40.
What are insiders doing with INMB?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on INMB?
Nov 6, 2026: INmune Bio Reports Third Quarter 2026 Financial Results · Nov 5, 2026: INmune Bio holds Q3 2026 earnings call · Nov 5, 2026: INmune Bio posts wider third-quarter loss than expected